[ Price : $8.95]
FDA grants Vivace Therapeutics an orphan drug designation for VT3989 and its use in treating mesothelioma.[ Price : $8.95]
Top House Democrats on the Energy and Commerce Committee raise alarm over what they describe as a coordinated effort by the Trump ...[ Price : $8.95]
FDA issues an online statement summarizing all its concerns with unapproved versions of GLP-1 weight loss drugs being marketed to ...[ Price : $8.95]
AbbVie files a supplemental NDA seeking approval for a new, fixed-duration, all-oral combination regimen of Venclexta (venetoclax)...[ Price : $8.95]
FDA says its Arthritis Advisory Committee is no longer worth the effort and expense needed to maintain it, and it has been termina...[ Price : $8.95]
FDA commissioner Martin Makary says he wants to find ways to get drugs to consumers faster, but also find ways to reduce the need ...[ Price : $8.95]
Newly appointed CBER director Vinay Prasad abruptly leaves the agency after being attacked by Trump influencer Laura Loomer for ex...[ Price : $8.95]
FDA grants Calidi Biotherapeutics fast-track status for CLD-201, an allogeneic stem-cell-loaded oncolytic virus being developed to...